New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
May 15, 2014
09:15 EDTCSCO, RGSE, XONE, VOXX, INCY, SRNE, PLUG, CLVS, KSS, BMY, AAP, LIQD, KND, GTIV, WMT, CAVM, AVGOOn The Fly: Pre-market Movers
HIGHER: Cisco (CSCO), up 8% after reporting better than expected third quarter results. Avago (AVGO) is also up 0.6% and Cavium (CAVM) is up 3% following Cisco's report... Gentiva Health (GTIV), up 60% after Kindred Healthcare (KND) proposes to acquire the company for $14.00 per share in cash and stock... Advance Auto Parts (AAP), up 3.3% after raising its outlook... Clovis (CLVS), up 7.7% after reporting drug data at ASCO conference... Plug Power (PLUG), up 2.4% following upgrade at Cowen. DOWN AFTER EARNINGS: Wal-Mart (WMT), down 2.9%... Kohl's (KSS), down 3.6%... ExOne (XONE), down 15%... Real Goods Solar (RGSE), down 13.7%. ALSO LOWER: Bristol-Myers (BMY), down 4% following downgrade at BMO Capital citing last nights' ASCO abstracts discussing disappointing Nivo-Yervfoy combination data... VOXX International (VOXX), down 25% after downgraded at B. Riley following worse than expected Q4 results... Sorrento Therapeutics (SRNE), down 21% after 4.765M share secondary stock offering priced at $5.25... Incyte (INCY), down 9.7% after an abstract regarding a Phase 2 study of its pancreatic cancer drug was posted at ASCO... Liquid Holdings (LIQD), down 43.5% after its 32M share secondary priced at $1.25.
News For CSCO;CAVM;WMT;GTIV;KND;LIQD;AAP;BMY;KSS;CLVS;PLUG;SRNE;INCY;VOXX;XONE;RGSE;AVGO From The Last 14 Days
Check below for free stories on CSCO;CAVM;WMT;GTIV;KND;LIQD;AAP;BMY;KSS;CLVS;PLUG;SRNE;INCY;VOXX;XONE;RGSE;AVGO the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | 4 | all recent news | >>
July 17, 2014
16:43 EDTGTIVGentiva Health up 11.5% after disclosing receipt of $17.25 takeover offer
Subscribe for More Information
16:42 EDTKND, GTIVGentiva says received $17.25 all-cash takeover bid, rejected Kindred $16 offer
Subscribe for More Information
16:36 EDTKND, GTIVGentiva Health rejects prior Kindred Healthcare proposal, receives alternate bid
Subscribe for More Information
08:08 EDTBMYBristol-Myers, Pfizer announce enrollment in Phase IV EMANATE trial for Eliquis
Subscribe for More Information
July 16, 2014
06:26 EDTBMYBristol-Myers lung cancer trials being underestimated, says Citigroup
After building a statistical model of Bristol-Myers' two critical registration trials for Opdivo in lung cancer, Citigroup believes the market is "materially" underestimating both Phase III trials. Citi says potential Opdivo FDA approval in 2015 in lung cancer would give Bristol-Myers an up to two year lead time versus Merck (MRK) and Roche (RHHBY). The firm estimates 2023 Opdivo revenue at $7B and reiterates a Buy rating on Bristol with a $60 price target.
July 15, 2014
13:15 EDTPLUGPlug Power jumps after analyst starts with Outperform rating
Subscribe for More Information
11:13 EDTBMYPerrigo retreats after analyst sees limited potential buyers
Subscribe for More Information
10:00 EDTPLUGOn The Fly: Analyst Initiation Summary
Subscribe for More Information
09:21 EDTPLUGOn The Fly: Pre-market Movers
Subscribe for More Information
08:35 EDTCSCOCisco announces multi-year sales, go-to-market agreement with Microsoft
Cisco (CSCO) announced a multi-year sales and go-to-market agreement with Microsoft (MSFT) designed to modernize data centers through the delivery and acceleration of integrated solutions. Cisco and Microsoft will both invest in sales, marketing and engineering resources to drive global alignment, while delivering deeper technology integration across cloud and data center markets. The companies will focus on integrating market leading technologies, including Cisco Unified Computing System, Cisco Nexus switching and Microsoft Cloud OS solutions including Windows Server, System Center, SQL Server and Microsoft Azure.
07:35 EDTBMYPerrigo potential buyers list could be limited, says Jefferies
After Globes reported that Perrigo retained an investment bank to assist with a potential merger, Jefferies says the list of potential buyers could be limited since the store brand business is fundamentally a high volume, lower margin model. The firm notes U.S. companies that currently do not have large over-the-counter divisions include Bristol-Myers (BMY), Eli Lilly (LLY) and Merck (MRK). Jefferies views the merger speculation surrounding Perrigo as not surprising given the company's strong long-term fundamentals and attractive Irish domicile. It has a Buy rating on the stock with a $160 price target.
05:53 EDTWMT, CSCOStocks with implied volatility movement; CSCO WMT
Stocks with implied volatility movement; Cisco (CSCO) 23, Wal-Mart (WMT) 13 according to iVolatility.
July 14, 2014
18:49 EDTPLUGPlug Power initiated with an Outperform at FBR Capital
Subscribe for More Information
18:33 EDTPLUGPlug Power up 7% following analyst initiation
Subscribe for More Information
12:06 EDTKND, GTIVGentiva Health urges holders to take no action in response to Kindred offer
Subscribe for More Information
10:00 EDTAVGOOn The Fly: Analyst Upgrade Summary
Subscribe for More Information
09:55 EDTGTIVHigh option volume stocks: PTEN MFRM GTIV SHPG IMMR
07:32 EDTKND, GTIVKindred Healthcare increases all-cash tender offer for Gentiva to $16 per share
Subscribe for More Information
07:32 EDTKND, GTIVKindred Healthcare increases all-cash tender offer for Gentiva to $16 per share
Subscribe for More Information
06:14 EDTAVGOAvago resumed with a Buy from Neutral at Citigroup
Subscribe for More Information
1 | 2 | 3 | 4 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use